nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—SLC12A3—respiratory system—lung cancer	0.0136	0.143	CbGeAlD
Methyclothiazide—SLC12A1—epithelium—lung cancer	0.00869	0.0914	CbGeAlD
Methyclothiazide—SLC12A3—lung—lung cancer	0.00723	0.0761	CbGeAlD
Methyclothiazide—CA1—respiratory system—lung cancer	0.00716	0.0753	CbGeAlD
Methyclothiazide—CA4—respiratory system—lung cancer	0.00559	0.0588	CbGeAlD
Methyclothiazide—CA2—respiratory system—lung cancer	0.00464	0.0488	CbGeAlD
Methyclothiazide—CA1—bone marrow—lung cancer	0.00419	0.0441	CbGeAlD
Methyclothiazide—CA4—trachea—lung cancer	0.00413	0.0435	CbGeAlD
Methyclothiazide—CA4—cardiac atrium—lung cancer	0.00388	0.0409	CbGeAlD
Methyclothiazide—CA2—epithelium—lung cancer	0.00388	0.0408	CbGeAlD
Methyclothiazide—CA2—bronchus—lung cancer	0.00382	0.0402	CbGeAlD
Methyclothiazide—CA1—lung—lung cancer	0.0038	0.04	CbGeAlD
Methyclothiazide—CA2—trachea—lung cancer	0.00343	0.0361	CbGeAlD
Methyclothiazide—CA4—bone marrow—lung cancer	0.00328	0.0345	CbGeAlD
Methyclothiazide—CA2—cardiac atrium—lung cancer	0.00322	0.0339	CbGeAlD
Methyclothiazide—CA4—lung—lung cancer	0.00297	0.0312	CbGeAlD
Methyclothiazide—CA2—bone marrow—lung cancer	0.00272	0.0286	CbGeAlD
Methyclothiazide—CA1—lymph node—lung cancer	0.0026	0.0273	CbGeAlD
Methyclothiazide—CA2—lung—lung cancer	0.00246	0.0259	CbGeAlD
Methyclothiazide—Hyperglycaemia—Paclitaxel—lung cancer	0.00233	0.00257	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Etoposide—lung cancer	0.00233	0.00257	CcSEcCtD
Methyclothiazide—Pneumonia—Paclitaxel—lung cancer	0.00231	0.00256	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Docetaxel—lung cancer	0.00231	0.00255	CcSEcCtD
Methyclothiazide—Paraesthesia—Topotecan—lung cancer	0.00229	0.00253	CcSEcCtD
Methyclothiazide—Jaundice—Etoposide—lung cancer	0.00229	0.00253	CcSEcCtD
Methyclothiazide—Decreased appetite—Vinblastine—lung cancer	0.00228	0.00252	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.00228	0.00252	CcSEcCtD
Methyclothiazide—Cramp muscle—Docetaxel—lung cancer	0.00228	0.00252	CcSEcCtD
Methyclothiazide—Constipation—Vinblastine—lung cancer	0.00224	0.00248	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Methotrexate—lung cancer	0.00224	0.00247	CcSEcCtD
Methyclothiazide—Decreased appetite—Topotecan—lung cancer	0.00222	0.00245	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Doxorubicin—lung cancer	0.00221	0.00245	CcSEcCtD
Methyclothiazide—Decreased appetite—Erlotinib—lung cancer	0.00219	0.00242	CcSEcCtD
Methyclothiazide—Agranulocytosis—Etoposide—lung cancer	0.00219	0.00242	CcSEcCtD
Methyclothiazide—Vomiting—Teniposide—lung cancer	0.00219	0.00242	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Vinorelbine—lung cancer	0.00218	0.00241	CcSEcCtD
Methyclothiazide—Constipation—Topotecan—lung cancer	0.00218	0.00241	CcSEcCtD
Methyclothiazide—Rash—Teniposide—lung cancer	0.00217	0.0024	CcSEcCtD
Methyclothiazide—Dermatitis—Teniposide—lung cancer	0.00217	0.00239	CcSEcCtD
Methyclothiazide—Constipation—Erlotinib—lung cancer	0.00216	0.00238	CcSEcCtD
Methyclothiazide—Headache—Teniposide—lung cancer	0.00215	0.00238	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Vinorelbine—lung cancer	0.00214	0.00236	CcSEcCtD
Methyclothiazide—Muscle spasms—Irinotecan—lung cancer	0.00212	0.00234	CcSEcCtD
Methyclothiazide—Anorexia—Vinorelbine—lung cancer	0.00208	0.0023	CcSEcCtD
Methyclothiazide—Photosensitivity—Methotrexate—lung cancer	0.00208	0.00229	CcSEcCtD
Methyclothiazide—Nausea—Teniposide—lung cancer	0.00204	0.00226	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Doxorubicin—lung cancer	0.00204	0.00226	CcSEcCtD
Methyclothiazide—CA4—lymph node—lung cancer	0.00203	0.0214	CbGeAlD
Methyclothiazide—Urticaria—Topotecan—lung cancer	0.00203	0.00224	CcSEcCtD
Methyclothiazide—Body temperature increased—Topotecan—lung cancer	0.00202	0.00223	CcSEcCtD
Methyclothiazide—Malnutrition—Cisplatin—lung cancer	0.002	0.00221	CcSEcCtD
Methyclothiazide—Body temperature increased—Erlotinib—lung cancer	0.00199	0.0022	CcSEcCtD
Methyclothiazide—Erythema multiforme—Etoposide—lung cancer	0.00199	0.0022	CcSEcCtD
Methyclothiazide—Vertigo—Irinotecan—lung cancer	0.00198	0.00219	CcSEcCtD
Methyclothiazide—Leukopenia—Irinotecan—lung cancer	0.00197	0.00218	CcSEcCtD
Methyclothiazide—Pneumonia—Docetaxel—lung cancer	0.00196	0.00217	CcSEcCtD
Methyclothiazide—Paraesthesia—Vinorelbine—lung cancer	0.00196	0.00216	CcSEcCtD
Methyclothiazide—Erythema multiforme—Paclitaxel—lung cancer	0.00195	0.00216	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Doxorubicin—lung cancer	0.00194	0.00214	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vinblastine—lung cancer	0.00193	0.00214	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00193	0.00214	CcSEcCtD
Methyclothiazide—Muscle spasms—Cisplatin—lung cancer	0.00192	0.00213	CcSEcCtD
Methyclothiazide—Leukopenia—Gemcitabine—lung cancer	0.00192	0.00212	CcSEcCtD
Methyclothiazide—Jaundice—Docetaxel—lung cancer	0.0019	0.0021	CcSEcCtD
Methyclothiazide—Decreased appetite—Vinorelbine—lung cancer	0.0019	0.00209	CcSEcCtD
Methyclothiazide—Vision blurred—Cisplatin—lung cancer	0.00189	0.00208	CcSEcCtD
Methyclothiazide—Asthenia—Vinblastine—lung cancer	0.00188	0.00208	CcSEcCtD
Methyclothiazide—Hypersensitivity—Topotecan—lung cancer	0.00188	0.00208	CcSEcCtD
Methyclothiazide—Constipation—Vinorelbine—lung cancer	0.00186	0.00206	CcSEcCtD
Methyclothiazide—Asthenia—Topotecan—lung cancer	0.00183	0.00202	CcSEcCtD
Methyclothiazide—Agranulocytosis—Docetaxel—lung cancer	0.00182	0.00201	CcSEcCtD
Methyclothiazide—Asthenia—Erlotinib—lung cancer	0.00181	0.002	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Irinotecan—lung cancer	0.0018	0.00199	CcSEcCtD
Methyclothiazide—Photosensitivity—Doxorubicin—lung cancer	0.0018	0.00199	CcSEcCtD
Methyclothiazide—Malnutrition—Paclitaxel—lung cancer	0.0018	0.00199	CcSEcCtD
Methyclothiazide—Diarrhoea—Vinblastine—lung cancer	0.0018	0.00198	CcSEcCtD
Methyclothiazide—Leukopenia—Cisplatin—lung cancer	0.00179	0.00198	CcSEcCtD
Methyclothiazide—Vascular purpura—Doxorubicin—lung cancer	0.00176	0.00195	CcSEcCtD
Methyclothiazide—Muscle spasms—Etoposide—lung cancer	0.00176	0.00195	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Irinotecan—lung cancer	0.00176	0.00195	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Gemcitabine—lung cancer	0.00175	0.00194	CcSEcCtD
Methyclothiazide—Diarrhoea—Topotecan—lung cancer	0.00174	0.00193	CcSEcCtD
Methyclothiazide—Dizziness—Vinblastine—lung cancer	0.00174	0.00192	CcSEcCtD
Methyclothiazide—Urticaria—Vinorelbine—lung cancer	0.00173	0.00191	CcSEcCtD
Methyclothiazide—Muscle spasms—Paclitaxel—lung cancer	0.00173	0.00191	CcSEcCtD
Methyclothiazide—Diarrhoea—Erlotinib—lung cancer	0.00173	0.00191	CcSEcCtD
Methyclothiazide—Body temperature increased—Vinorelbine—lung cancer	0.00172	0.00191	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Gemcitabine—lung cancer	0.00172	0.0019	CcSEcCtD
Methyclothiazide—Anorexia—Irinotecan—lung cancer	0.00171	0.00189	CcSEcCtD
Methyclothiazide—Vision blurred—Paclitaxel—lung cancer	0.00169	0.00187	CcSEcCtD
Methyclothiazide—Dizziness—Topotecan—lung cancer	0.00169	0.00186	CcSEcCtD
Methyclothiazide—CA2—lymph node—lung cancer	0.00168	0.0177	CbGeAlD
Methyclothiazide—Anorexia—Gemcitabine—lung cancer	0.00167	0.00185	CcSEcCtD
Methyclothiazide—Vomiting—Vinblastine—lung cancer	0.00167	0.00184	CcSEcCtD
Methyclothiazide—Dizziness—Erlotinib—lung cancer	0.00167	0.00184	CcSEcCtD
Methyclothiazide—Erythema multiforme—Docetaxel—lung cancer	0.00165	0.00183	CcSEcCtD
Methyclothiazide—Agitation—Paclitaxel—lung cancer	0.00165	0.00183	CcSEcCtD
Methyclothiazide—Vertigo—Etoposide—lung cancer	0.00165	0.00182	CcSEcCtD
Methyclothiazide—Headache—Vinblastine—lung cancer	0.00164	0.00182	CcSEcCtD
Methyclothiazide—Leukopenia—Etoposide—lung cancer	0.00164	0.00181	CcSEcCtD
Methyclothiazide—Purpura—Doxorubicin—lung cancer	0.00164	0.00181	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Cisplatin—lung cancer	0.00163	0.0018	CcSEcCtD
Methyclothiazide—Vomiting—Topotecan—lung cancer	0.00162	0.00179	CcSEcCtD
Methyclothiazide—Paraesthesia—Irinotecan—lung cancer	0.00162	0.00178	CcSEcCtD
Methyclothiazide—Vertigo—Paclitaxel—lung cancer	0.00161	0.00178	CcSEcCtD
Methyclothiazide—Leukopenia—Paclitaxel—lung cancer	0.00161	0.00178	CcSEcCtD
Methyclothiazide—Rash—Topotecan—lung cancer	0.00161	0.00178	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vinorelbine—lung cancer	0.00161	0.00178	CcSEcCtD
Methyclothiazide—Dermatitis—Topotecan—lung cancer	0.00161	0.00177	CcSEcCtD
Methyclothiazide—Vomiting—Erlotinib—lung cancer	0.0016	0.00177	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Cisplatin—lung cancer	0.0016	0.00177	CcSEcCtD
Methyclothiazide—Headache—Topotecan—lung cancer	0.0016	0.00176	CcSEcCtD
Methyclothiazide—Rash—Erlotinib—lung cancer	0.00159	0.00176	CcSEcCtD
Methyclothiazide—Dermatitis—Erlotinib—lung cancer	0.00159	0.00176	CcSEcCtD
Methyclothiazide—Headache—Erlotinib—lung cancer	0.00158	0.00175	CcSEcCtD
Methyclothiazide—Paraesthesia—Gemcitabine—lung cancer	0.00157	0.00174	CcSEcCtD
Methyclothiazide—Asthenia—Vinorelbine—lung cancer	0.00156	0.00173	CcSEcCtD
Methyclothiazide—Decreased appetite—Irinotecan—lung cancer	0.00156	0.00173	CcSEcCtD
Methyclothiazide—Nausea—Vinblastine—lung cancer	0.00156	0.00172	CcSEcCtD
Methyclothiazide—Anorexia—Cisplatin—lung cancer	0.00156	0.00172	CcSEcCtD
Methyclothiazide—Pancreatitis—Methotrexate—lung cancer	0.00155	0.00171	CcSEcCtD
Methyclothiazide—Constipation—Irinotecan—lung cancer	0.00154	0.0017	CcSEcCtD
Methyclothiazide—Malnutrition—Docetaxel—lung cancer	0.00152	0.00168	CcSEcCtD
Methyclothiazide—Decreased appetite—Gemcitabine—lung cancer	0.00152	0.00168	CcSEcCtD
Methyclothiazide—Nausea—Topotecan—lung cancer	0.00151	0.00167	CcSEcCtD
Methyclothiazide—Constipation—Gemcitabine—lung cancer	0.0015	0.00166	CcSEcCtD
Methyclothiazide—Nausea—Erlotinib—lung cancer	0.0015	0.00166	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Etoposide—lung cancer	0.0015	0.00165	CcSEcCtD
Methyclothiazide—Diarrhoea—Vinorelbine—lung cancer	0.00149	0.00165	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Paclitaxel—lung cancer	0.00147	0.00162	CcSEcCtD
Methyclothiazide—Paraesthesia—Cisplatin—lung cancer	0.00147	0.00162	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Etoposide—lung cancer	0.00146	0.00162	CcSEcCtD
Methyclothiazide—Muscle spasms—Docetaxel—lung cancer	0.00146	0.00162	CcSEcCtD
Methyclothiazide—Dizziness—Vinorelbine—lung cancer	0.00144	0.00159	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Doxorubicin—lung cancer	0.00144	0.00159	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Methotrexate—lung cancer	0.00144	0.00159	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Paclitaxel—lung cancer	0.00144	0.00159	CcSEcCtD
Methyclothiazide—Anorexia—Etoposide—lung cancer	0.00143	0.00158	CcSEcCtD
Methyclothiazide—Body temperature increased—Irinotecan—lung cancer	0.00142	0.00157	CcSEcCtD
Methyclothiazide—Decreased appetite—Cisplatin—lung cancer	0.00142	0.00157	CcSEcCtD
Methyclothiazide—Pneumonia—Methotrexate—lung cancer	0.00141	0.00156	CcSEcCtD
Methyclothiazide—Anorexia—Paclitaxel—lung cancer	0.0014	0.00155	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00139	0.00154	CcSEcCtD
Methyclothiazide—Vomiting—Vinorelbine—lung cancer	0.00139	0.00153	CcSEcCtD
Methyclothiazide—Body temperature increased—Gemcitabine—lung cancer	0.00139	0.00153	CcSEcCtD
Methyclothiazide—Rash—Vinorelbine—lung cancer	0.00138	0.00152	CcSEcCtD
Methyclothiazide—Dermatitis—Vinorelbine—lung cancer	0.00137	0.00152	CcSEcCtD
Methyclothiazide—Headache—Vinorelbine—lung cancer	0.00137	0.00151	CcSEcCtD
Methyclothiazide—Leukopenia—Docetaxel—lung cancer	0.00136	0.00151	CcSEcCtD
Methyclothiazide—Paraesthesia—Etoposide—lung cancer	0.00134	0.00148	CcSEcCtD
Methyclothiazide—Pancreatitis—Doxorubicin—lung cancer	0.00134	0.00148	CcSEcCtD
Methyclothiazide—Hypersensitivity—Irinotecan—lung cancer	0.00133	0.00146	CcSEcCtD
Methyclothiazide—Paraesthesia—Paclitaxel—lung cancer	0.00132	0.00146	CcSEcCtD
Methyclothiazide—Agranulocytosis—Methotrexate—lung cancer	0.00131	0.00145	CcSEcCtD
Methyclothiazide—Decreased appetite—Etoposide—lung cancer	0.0013	0.00144	CcSEcCtD
Methyclothiazide—Nausea—Vinorelbine—lung cancer	0.0013	0.00143	CcSEcCtD
Methyclothiazide—Body temperature increased—Cisplatin—lung cancer	0.00129	0.00143	CcSEcCtD
Methyclothiazide—Asthenia—Irinotecan—lung cancer	0.00129	0.00143	CcSEcCtD
Methyclothiazide—Constipation—Etoposide—lung cancer	0.00128	0.00141	CcSEcCtD
Methyclothiazide—Decreased appetite—Paclitaxel—lung cancer	0.00128	0.00141	CcSEcCtD
Methyclothiazide—Asthenia—Gemcitabine—lung cancer	0.00126	0.00139	CcSEcCtD
Methyclothiazide—Constipation—Paclitaxel—lung cancer	0.00125	0.00139	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—lung cancer	0.00125	0.00138	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Docetaxel—lung cancer	0.00124	0.00137	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—lung cancer	0.00123	0.00136	CcSEcCtD
Methyclothiazide—Diarrhoea—Irinotecan—lung cancer	0.00123	0.00136	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—lung cancer	0.00122	0.00135	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Docetaxel—lung cancer	0.00122	0.00135	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00121	0.00133	CcSEcCtD
Methyclothiazide—Hypersensitivity—Cisplatin—lung cancer	0.0012	0.00133	CcSEcCtD
Methyclothiazide—Diarrhoea—Gemcitabine—lung cancer	0.0012	0.00132	CcSEcCtD
Methyclothiazide—Erythema multiforme—Methotrexate—lung cancer	0.00119	0.00132	CcSEcCtD
Methyclothiazide—Dizziness—Irinotecan—lung cancer	0.00119	0.00131	CcSEcCtD
Methyclothiazide—Urticaria—Etoposide—lung cancer	0.00119	0.00131	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—lung cancer	0.00119	0.00131	CcSEcCtD
Methyclothiazide—Anorexia—Docetaxel—lung cancer	0.00119	0.00131	CcSEcCtD
Methyclothiazide—Body temperature increased—Etoposide—lung cancer	0.00118	0.00131	CcSEcCtD
Methyclothiazide—Asthenia—Cisplatin—lung cancer	0.00117	0.00129	CcSEcCtD
Methyclothiazide—Urticaria—Paclitaxel—lung cancer	0.00117	0.00129	CcSEcCtD
Methyclothiazide—Body temperature increased—Paclitaxel—lung cancer	0.00116	0.00128	CcSEcCtD
Methyclothiazide—Vomiting—Irinotecan—lung cancer	0.00114	0.00126	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—lung cancer	0.00114	0.00125	CcSEcCtD
Methyclothiazide—Rash—Irinotecan—lung cancer	0.00113	0.00125	CcSEcCtD
Methyclothiazide—Dermatitis—Irinotecan—lung cancer	0.00113	0.00125	CcSEcCtD
Methyclothiazide—Headache—Irinotecan—lung cancer	0.00113	0.00125	CcSEcCtD
Methyclothiazide—Diarrhoea—Cisplatin—lung cancer	0.00112	0.00123	CcSEcCtD
Methyclothiazide—Paraesthesia—Docetaxel—lung cancer	0.00112	0.00123	CcSEcCtD
Methyclothiazide—Vomiting—Gemcitabine—lung cancer	0.00111	0.00123	CcSEcCtD
Methyclothiazide—Rash—Gemcitabine—lung cancer	0.0011	0.00122	CcSEcCtD
Methyclothiazide—Dermatitis—Gemcitabine—lung cancer	0.0011	0.00122	CcSEcCtD
Methyclothiazide—Hypersensitivity—Etoposide—lung cancer	0.0011	0.00122	CcSEcCtD
Methyclothiazide—Malnutrition—Methotrexate—lung cancer	0.0011	0.00121	CcSEcCtD
Methyclothiazide—Headache—Gemcitabine—lung cancer	0.0011	0.00121	CcSEcCtD
Methyclothiazide—Decreased appetite—Docetaxel—lung cancer	0.00108	0.00119	CcSEcCtD
Methyclothiazide—Hypersensitivity—Paclitaxel—lung cancer	0.00108	0.00119	CcSEcCtD
Methyclothiazide—Asthenia—Etoposide—lung cancer	0.00107	0.00119	CcSEcCtD
Methyclothiazide—Nausea—Irinotecan—lung cancer	0.00107	0.00118	CcSEcCtD
Methyclothiazide—Constipation—Docetaxel—lung cancer	0.00106	0.00117	CcSEcCtD
Methyclothiazide—Asthenia—Paclitaxel—lung cancer	0.00105	0.00116	CcSEcCtD
Methyclothiazide—Nausea—Gemcitabine—lung cancer	0.00104	0.00115	CcSEcCtD
Methyclothiazide—Vomiting—Cisplatin—lung cancer	0.00104	0.00115	CcSEcCtD
Methyclothiazide—Vision blurred—Methotrexate—lung cancer	0.00103	0.00114	CcSEcCtD
Methyclothiazide—Erythema multiforme—Doxorubicin—lung cancer	0.00103	0.00114	CcSEcCtD
Methyclothiazide—Rash—Cisplatin—lung cancer	0.00103	0.00114	CcSEcCtD
Methyclothiazide—Dermatitis—Cisplatin—lung cancer	0.00103	0.00114	CcSEcCtD
Methyclothiazide—Diarrhoea—Etoposide—lung cancer	0.00102	0.00113	CcSEcCtD
Methyclothiazide—Diarrhoea—Paclitaxel—lung cancer	0.001	0.00111	CcSEcCtD
Methyclothiazide—Dizziness—Etoposide—lung cancer	0.000989	0.00109	CcSEcCtD
Methyclothiazide—Vertigo—Methotrexate—lung cancer	0.000987	0.00109	CcSEcCtD
Methyclothiazide—Body temperature increased—Docetaxel—lung cancer	0.000983	0.00109	CcSEcCtD
Methyclothiazide—Leukopenia—Methotrexate—lung cancer	0.000983	0.00109	CcSEcCtD
Methyclothiazide—Dizziness—Paclitaxel—lung cancer	0.00097	0.00107	CcSEcCtD
Methyclothiazide—Nausea—Cisplatin—lung cancer	0.00097	0.00107	CcSEcCtD
Methyclothiazide—Vomiting—Etoposide—lung cancer	0.000951	0.00105	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—lung cancer	0.000951	0.00105	CcSEcCtD
Methyclothiazide—Rash—Etoposide—lung cancer	0.000943	0.00104	CcSEcCtD
Methyclothiazide—Dermatitis—Etoposide—lung cancer	0.000942	0.00104	CcSEcCtD
Methyclothiazide—Headache—Etoposide—lung cancer	0.000937	0.00104	CcSEcCtD
Methyclothiazide—Vomiting—Paclitaxel—lung cancer	0.000933	0.00103	CcSEcCtD
Methyclothiazide—Rash—Paclitaxel—lung cancer	0.000925	0.00102	CcSEcCtD
Methyclothiazide—Dermatitis—Paclitaxel—lung cancer	0.000924	0.00102	CcSEcCtD
Methyclothiazide—Headache—Paclitaxel—lung cancer	0.000919	0.00102	CcSEcCtD
Methyclothiazide—Hypersensitivity—Docetaxel—lung cancer	0.000916	0.00101	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—lung cancer	0.000914	0.00101	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Methotrexate—lung cancer	0.000896	0.00099	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—lung cancer	0.000896	0.00099	CcSEcCtD
Methyclothiazide—Asthenia—Docetaxel—lung cancer	0.000892	0.000986	CcSEcCtD
Methyclothiazide—Nausea—Etoposide—lung cancer	0.000889	0.000982	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Methotrexate—lung cancer	0.000877	0.00097	CcSEcCtD
Methyclothiazide—Agitation—Doxorubicin—lung cancer	0.000874	0.000966	CcSEcCtD
Methyclothiazide—Nausea—Paclitaxel—lung cancer	0.000871	0.000963	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—lung cancer	0.000854	0.000944	CcSEcCtD
Methyclothiazide—Anorexia—Methotrexate—lung cancer	0.000854	0.000944	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—lung cancer	0.000851	0.00094	CcSEcCtD
Methyclothiazide—Diarrhoea—Docetaxel—lung cancer	0.000851	0.00094	CcSEcCtD
Methyclothiazide—Dizziness—Docetaxel—lung cancer	0.000822	0.000909	CcSEcCtD
Methyclothiazide—Paraesthesia—Methotrexate—lung cancer	0.000805	0.000889	CcSEcCtD
Methyclothiazide—Vomiting—Docetaxel—lung cancer	0.000791	0.000874	CcSEcCtD
Methyclothiazide—Rash—Docetaxel—lung cancer	0.000784	0.000866	CcSEcCtD
Methyclothiazide—Dermatitis—Docetaxel—lung cancer	0.000783	0.000866	CcSEcCtD
Methyclothiazide—Decreased appetite—Methotrexate—lung cancer	0.000779	0.000861	CcSEcCtD
Methyclothiazide—Headache—Docetaxel—lung cancer	0.000779	0.000861	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—lung cancer	0.000776	0.000857	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Doxorubicin—lung cancer	0.00076	0.00084	CcSEcCtD
Methyclothiazide—Anorexia—Doxorubicin—lung cancer	0.00074	0.000817	CcSEcCtD
Methyclothiazide—Nausea—Docetaxel—lung cancer	0.000739	0.000816	CcSEcCtD
Methyclothiazide—Urticaria—Methotrexate—lung cancer	0.000712	0.000787	CcSEcCtD
Methyclothiazide—Body temperature increased—Methotrexate—lung cancer	0.000708	0.000783	CcSEcCtD
Methyclothiazide—Paraesthesia—Doxorubicin—lung cancer	0.000697	0.00077	CcSEcCtD
Methyclothiazide—Decreased appetite—Doxorubicin—lung cancer	0.000675	0.000745	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—lung cancer	0.000664	0.000733	CcSEcCtD
Methyclothiazide—Hypersensitivity—Methotrexate—lung cancer	0.00066	0.00073	CcSEcCtD
Methyclothiazide—Asthenia—Methotrexate—lung cancer	0.000643	0.000711	CcSEcCtD
Methyclothiazide—Urticaria—Doxorubicin—lung cancer	0.000616	0.000681	CcSEcCtD
Methyclothiazide—Body temperature increased—Doxorubicin—lung cancer	0.000613	0.000678	CcSEcCtD
Methyclothiazide—Diarrhoea—Methotrexate—lung cancer	0.000613	0.000678	CcSEcCtD
Methyclothiazide—Dizziness—Methotrexate—lung cancer	0.000593	0.000655	CcSEcCtD
Methyclothiazide—Hypersensitivity—Doxorubicin—lung cancer	0.000572	0.000632	CcSEcCtD
Methyclothiazide—Vomiting—Methotrexate—lung cancer	0.00057	0.00063	CcSEcCtD
Methyclothiazide—Rash—Methotrexate—lung cancer	0.000565	0.000624	CcSEcCtD
Methyclothiazide—Dermatitis—Methotrexate—lung cancer	0.000565	0.000624	CcSEcCtD
Methyclothiazide—Headache—Methotrexate—lung cancer	0.000561	0.00062	CcSEcCtD
Methyclothiazide—Asthenia—Doxorubicin—lung cancer	0.000557	0.000615	CcSEcCtD
Methyclothiazide—Nausea—Methotrexate—lung cancer	0.000532	0.000588	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—lung cancer	0.000531	0.000587	CcSEcCtD
Methyclothiazide—Dizziness—Doxorubicin—lung cancer	0.000513	0.000567	CcSEcCtD
Methyclothiazide—Vomiting—Doxorubicin—lung cancer	0.000493	0.000545	CcSEcCtD
Methyclothiazide—Rash—Doxorubicin—lung cancer	0.000489	0.000541	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—lung cancer	0.000489	0.00054	CcSEcCtD
Methyclothiazide—Headache—Doxorubicin—lung cancer	0.000486	0.000537	CcSEcCtD
Methyclothiazide—Nausea—Doxorubicin—lung cancer	0.000461	0.000509	CcSEcCtD
